Literature DB >> 17007047

Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease.

E Louise Thomas1, Audrey E Brynes, Gavin Hamilton, Nayna Patel, Adam Spong, Robert D Goldin, Gary Frost, Jimmy D Bell, Simon D Taylor-Robinson.   

Abstract

AIM: To assess the effectiveness of the current UK clinical practice in reducing hepatic fat (IHCL).
METHODS: Whole body MRI and (1)H MRS were obtained, before and after 6 mo nutritional counselling, from liver, soleus and tibialis muscles in 10 subjects with non-alcoholic fatty liver disease (NAFLD).
RESULTS: A 500 Kcal-restricted diet resulted in an average weight loss of 4% (-3.4 kg,) accompanied by significant reductions in most adipose tissue (AT) depots, including subcutaneous (-9.9%), abdominal subcutaneous (-10.2%) and intra-abdominal-AT (-11.4%). Intramyocellular lipids (IMCL) were significantly reduced in the tibialis muscle (-28.2%). Decreases in both IHCL (-39.9%) and soleus IMCL (-12.2%) content were also observed, although these were not significant. Several individuals showed dramatic decreases in IHCL, while others paradoxically showed increases in IHCL content. Changes in body composition were accompanied by improvements in certain liver function tests: serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Significant correlations were found between decreases in IHCL and reductions in both intra-abdominal and abdominal subcutaneous AT. Improvements in liver function tests were associated with reductions in intra-abdominal AT, but not with changes in IHCL.
CONCLUSION: This study shows that even a very modest reduction in body weight achieved through lifestyle modification can result in changes in body fat depots and improvements in LFTs.

Entities:  

Mesh:

Year:  2006        PMID: 17007047      PMCID: PMC4100662          DOI: 10.3748/wjg.v12.i36.5813

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  45 in total

1.  Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

Authors:  T Ueno; H Sugawara; K Sujaku; O Hashimoto; R Tsuji; S Tamaki; T Torimura; S Inuzuka; M Sata; K Tanikawa
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

2.  Hepatic effects of dietary weight loss in morbidly obese subjects.

Authors:  T Andersen; C Gluud; M B Franzmann; P Christoffersen
Journal:  J Hepatol       Date:  1991-03       Impact factor: 25.083

3.  Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.

Authors:  I R Wanless; J S Lentz
Journal:  Hepatology       Date:  1990-11       Impact factor: 17.425

4.  Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans.

Authors:  C Thamer; J Machann; O Tschritter; M Haap; B Wietek; D Dahl; O Bachmann; A Fritsche; S Jacob; M Stumvoll; F Schick; H-U Häring
Journal:  Horm Metab Res       Date:  2002 Nov-Dec       Impact factor: 2.936

5.  Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty.

Authors:  F H Luyckx; C Desaive; A Thiry; W Dewé; A J Scheen; J E Gielen; P J Lefèbvre
Journal:  Int J Obes Relat Metab Disord       Date:  1998-03

6.  Waist circumference as a measure for indicating need for weight management.

Authors:  M E Lean; T S Han; C E Morrison
Journal:  BMJ       Date:  1995-07-15

7.  The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.

Authors:  E E Powell; W G Cooksley; R Hanson; J Searle; J W Halliday; L W Powell
Journal:  Hepatology       Date:  1990-01       Impact factor: 17.425

8.  A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients.

Authors:  S A Harrison; C Fincke; D Helinski; S Torgerson; P Hayashi
Journal:  Aliment Pharmacol Ther       Date:  2004-09-15       Impact factor: 8.171

9.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

Authors:  John B Dixon; Prithi S Bhathal; Norman R Hughes; Paul E O'Brien
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  Effect of weight control on hepatic abnormalities in obese patients with fatty liver.

Authors:  H S Park; M W Kim; E S Shin
Journal:  J Korean Med Sci       Date:  1995-12       Impact factor: 2.153

View more
  38 in total

1.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

2.  Current status of therapy in nonalcoholic Fatty liver disease.

Authors:  Scott McNear; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 3.  Benefits of lifestyle modification in NAFLD.

Authors:  Stephen A Harrison; Christopher Paul Day
Journal:  Gut       Date:  2007-10-02       Impact factor: 23.059

4.  Common genetic variations in CLOCK transcription factor are associated with nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo Castaño; Carolina Gemma; Tomas-Fernández Gianotti; Carlos-Jose Pirola
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

Review 5.  Liver fat content determined by magnetic resonance imaging and spectroscopy.

Authors:  Fabian Springer; Jürgen Machann; Claus D Claussen; Fritz Schick; Nina F Schwenzer
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 6.  Effects of physical activity upon the liver.

Authors:  Roy J Shephard; Nathan Johnson
Journal:  Eur J Appl Physiol       Date:  2014-11-04       Impact factor: 3.078

7.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

8.  Non-invasive means of measuring hepatic fat content.

Authors:  Sanjeev-R Mehta; E-Louise Thomas; Jimmy-D Bell; Desmond-G Johnston; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes.

Authors:  Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark
Journal:  Diabetes Care       Date:  2010-07-27       Impact factor: 19.112

10.  Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease.

Authors:  Yoichiro Kitajima; Yuichiro Eguchi; Eriko Ishibashi; Shunya Nakashita; Shigehisa Aoki; Shuji Toda; Toshihiko Mizuta; Iwata Ozaki; Naofumi Ono; Takahisa Eguchi; Kohei Arai; Ryuichi Iwakiri; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-11-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.